6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Cognitive Enhancers in Addiction Recovery
Cognitive enhancers, also known as nootropics, are emerging as promising tools in addiction recovery. These substances aim to improve cognitive functions like memory, attention, and decision-making, which are often impaired by prolonged substance use. Medications such as modafinil, bupropion, and acetylcysteine have shown potential in reducing cravings and supporting cognitive recovery. These drugs work by modulating neurotransmitter systems, including dopamine and glutamate, to restore balance in the brain. Cognitive training programs, combined with these enhancers, further boost recovery outcomes by strengthening executive functions. While research is ongoing, the integration of cognitive enhancers offers a novel dimension to addiction treatment, improving both neurological health and quality of life.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States